Industrial Manufacturing and Synthesis Route of Methyl 3-Aminocrotonate for Pharmaceutical Applications
- High-Yield Synthesis: Optimized ammonolysis of methyl acetoacetate ensures yields exceeding 75% with minimal byproduct formation.
- Pharmaceutical Grade: Strict control of acetoacetamide impurities guarantees suitability for calcium channel blocker production.
- Global Supply Chain: Reliable bulk procurement supported by comprehensive COA and GMP-standard manufacturing protocols.
Methyl 3-Aminocrotonate (CAS: 14205-39-1) serves as a critical intermediate in the synthesis of 1,4-dihydropyridine calcium channel blockers, including nicardipine and nitrendipine. For process chemists and procurement managers, securing a consistent supply of this organic building block is essential for maintaining downstream drug production efficiency. The compound, chemically identified as Methyl 3-amino-2-butenoate, typically presents as an off-white to light yellow crystalline powder with a molecular weight of 115.13 g/mol. Understanding the technical nuances of its production is vital for ensuring batch-to-batch consistency in large-scale pharmaceutical manufacturing.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. specializes in delivering high-specification intermediates that meet rigorous international standards. This article details the optimized synthesis route, impurity control mechanisms, and commercial considerations for sourcing this key chemical entity.
Optimized Synthesis Route via Ammonolysis
The industrial production of 3-Aminocrotonic Acid Methyl Ester primarily relies on the ammonolysis of methyl acetoacetate. Historical methods often utilized anhydrous ammonia in ether solvents, which posed significant safety risks regarding flammability and explosion hazards. Modern industrial processes have shifted toward aqueous systems to enhance safety and scalability.
The reaction involves treating methyl acetoacetate with ammonia or ammonium hydroxide in the presence of water. Critical process parameters include maintaining a reaction temperature between 35°C and 70°C. Operating within the preferred range of 40°C to 45°C when using ammonium hydroxide allows for controlled exothermic management. This thermal control is crucial to prevent the formation of undesired side products.
Key reaction conditions for optimal yield include:
- Molar Ratio: Utilizing 1.5 to 4.0 molar equivalents of ammonia per mole of methyl acetoacetate ensures complete conversion.
- Water Content: The presence of 0.05 to 3.0 molar equivalents of water facilitates the reaction medium without hydrolyzing the ester group excessively.
- Precipitation: The product typically precipitates as crystals upon cooling the reaction mixture to 0°C to 5°C, simplifying isolation via filtration.
By adhering to these parameters, manufacturers can achieve yields upwards of 76% with high structural integrity. The elimination of organic solvents like ether not only improves safety but also reduces the environmental footprint of the manufacturing process.
Impurity Control and Industrial Purity Standards
The primary challenge in the manufacture of 2-Butenoic acid 3-amino methyl ester is the suppression of acetoacetamide formation. Acetoacetamide is a persistent byproduct that can interfere with subsequent cyclization reactions required to form dihydropyridine structures. If not removed, these contaminants can complicate purification steps in the final drug substance manufacturing.
Advanced manufacturing protocols employ rigorous crystallization and washing steps to ensure industrial purity. Gas-liquid chromatography (GLC) and High-Performance Liquid Chromatography (HPLC) are standard analytical methods used to verify assay values typically exceeding 98.0%. Recrystallization from ethanol or water further enhances purity profiles, ensuring the melting point remains within the strict range of 81°C to 86°C.
For procurement professionals, verifying the Certificate of Analysis (COA) for specific impurity limits is non-negotiable. High-quality batches should demonstrate negligible levels of starting materials and side reactions, ensuring seamless integration into continuous flow synthesis or batch reactors.
Commercial Procurement and Bulk Supply Dynamics
Sourcing this intermediate requires a partner capable of scaling production to meet fluctuating pharmaceutical demand. The bulk price of Methyl 3-Aminocrotonate is influenced by raw material costs, specifically methyl acetoacetate and ammonia, as well as energy requirements for cooling and crystallization. Established manufacturers offer stability in pricing through long-term supply agreements and efficient production scheduling.
When evaluating potential vendors, buyers should prioritize facilities that adhere to GMP standards and can provide comprehensive technical support. Reliability in the supply chain prevents production bottlenecks for downstream antihypertensive medications. For detailed specifications and availability, professionals often review the product page for Methyl 3-Aminocrotonate to ensure alignment with their specific process requirements.
NINGBO INNO PHARMCHEM CO.,LTD. maintains a robust inventory system to support both research quantities and multi-ton commercial orders. This flexibility allows clients to scale from clinical trial phases to full commercialization without changing suppliers, thereby reducing regulatory validation burdens.
Technical Specifications and Physical Properties
The following table outlines the standard physical and chemical properties expected from a high-grade manufacturer. These specifications serve as a benchmark for quality assurance teams during incoming material inspection.
| Property | Specification |
|---|---|
| Chemical Name | Methyl 3-aminocrotonate |
| CAS Number | 14205-39-1 |
| Molecular Formula | C5H9NO2 |
| Molecular Weight | 115.13 g/mol |
| Appearance | Off-white to light yellow crystalline powder |
| Melting Point | 81°C - 86°C |
| Assay (GC/HPLC) | ≥ 98.0% |
| Key Impurity | Acetoacetamide (Controlled < 0.5%) |
Conclusion
The effective procurement of Methyl 3-Aminocrotonate hinges on understanding its synthesis chemistry and partnering with reliable manufacturers. By focusing on purity, quality adherence, and supplier reliability, businesses can optimize their synthesis processes and ensure the successful production of essential pharmaceuticals. NINGBO INNO PHARMCHEM CO.,LTD. remains committed to providing not only high-quality intermediates but also comprehensive support to facilitate seamless procurement and production workflows.